These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7177375)

  • 1. Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.
    Bassi P; Cecchini A; Dettori P; Signorini E
    Neuroradiology; 1982; 24(2):85-90. PubMed ID: 7177375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with iopamidol for myelography.
    Bockenheimer SA; Hillesheimer W
    AJNR Am J Neuroradiol; 1983; 4(3):314-6. PubMed ID: 6410731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iopamidol (B 15000), a nonionic water-soluble contrast medium for neuroradiology. Part I: Results of a clinical trial for myelography.
    Bacarini L; de Nicola T; Gasparini D; Orlando P; Vassallo A
    Neuroradiology; 1982; 23(2):81-4. PubMed ID: 7043305
    [No Abstract]   [Full Text] [Related]  

  • 4. Iopamidol in lumbar myelography.
    Kleefield J; Chirico-Post J; Levine HL; Srinivasan MK; Harris JM; Rommel AJ; Robbins AH
    Surg Neurol; 1983 Aug; 20(2):165-70. PubMed ID: 6224304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].
    Smaltino F; Ciccarelli R; Cirillo S; D'Auria T; Gambardella A; La Tessa G; Meoli S; Rotondo A; Santoro S
    Radiol Med; 1980 Apr; 66(4):203-10. PubMed ID: 7005985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient lumbar myelography. Analysis of complications after myelography comparing outpatients with inpatients.
    Postacchini F; Massobrio M
    Spine (Phila Pa 1976); 1985; 10(6):567-70. PubMed ID: 4081870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iohexol vs. iopamidol for myelography.
    Lamb JT
    Invest Radiol; 1985; 20(1 Suppl):S37-43. PubMed ID: 3882615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography.
    Vézina JL; Fox AJ
    J Can Assoc Radiol; 1984 Sep; 35(3):257-8. PubMed ID: 6501380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical evaluation of a new water soluble contrast medium (Iopamidolo) in cervical myelograms.
    Tanghetti B; Giunta F; Marini G; Orlandini A; Gualandi GF
    J Neurosurg Sci; 1982; 26(3):169-72. PubMed ID: 7182435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
    Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
    J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of radiographic quality and adverse reactions in myelography with iopamidol and metrizamide.
    Bannon KR; Braun IF; Pinto RS; Manuell M; Sudilovsky A; Kricheff II
    AJNR Am J Neuroradiol; 1983; 4(3):312-3. PubMed ID: 6410730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iopamidol and metrizamide in cervical myelography: side effects, EEG, and CSF changes.
    Moschini L; Manara O; Bonaldi G; Cassinari V; Quilici N; Belloni G
    AJNR Am J Neuroradiol; 1983; 4(3):848-50. PubMed ID: 6410870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical myelography with iopamidolo.
    Belloni G; Bonaldi G; Moschini L; Quilici N
    Neuroradiology; 1981 Mar; 21(2):97-9. PubMed ID: 7207817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.
    Hammer B; Lackner W
    Neuroradiology; 1980 Apr; 19(3):119-21. PubMed ID: 6991972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelography with lopamidol.
    Lamb JT; Holland IM
    AJNR Am J Neuroradiol; 1983; 4(3):851-3. PubMed ID: 6410871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iopamidol and metrizamide for myelography: prospective double-blind clinical trial.
    Witwer G; Cacayorin ED; Bernstein AD; Hubballah MY; Yuan HA; Kieffer SA
    AJR Am J Roentgenol; 1984 Oct; 143(4):869-73. PubMed ID: 6382981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Side effects and contrast medium resorption of iopamidol and iocarmate in lumbar myelography].
    Stoeter P; Bergleiter R; Schneider I; Kubina FG
    Computertomographie; 1982 Dec; 2(4):179-83. PubMed ID: 6821243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iopamidol (B 15,000), a nonionic water-soluble contrast medium for neuroradiology. part II: results of a double-blind study of the lumbar epidural venous plexuses.
    Bacarini L; de Nicola T; Gasparini D; Orlando P; Vassallo A
    Neuroradiology; 1982; 23(3):147-52. PubMed ID: 6211636
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct puncture versus run up cervical myelography with iopamidol: a comparison of side effects, EEG changes and radiographic quality.
    Macpherson P; Teasdale E; McGeorge AP
    J Neurol Neurosurg Psychiatry; 1983 Oct; 46(10):959-62. PubMed ID: 6644321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F; van Dongen K; Hekster R; Hoogland P; Thijssen H; Tjian T; Wilmink J; Althuisius H
    Diagn Imaging; 1983; 52(6):313-5. PubMed ID: 6357678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.